Literature DB >> 27246823

Pseudomonas aeruginosa Cell Membrane Protein Expression from Phenotypically Diverse Cystic Fibrosis Isolates Demonstrates Host-Specific Adaptations.

Karthik Shantharam Kamath1, Dana Pascovici2, Anahit Penesyan1, Apurv Goel2, Vignesh Venkatakrishnan1, Ian T Paulsen1, Nicolle H Packer1, Mark P Molloy1,2.   

Abstract

Pseudomonas aeruginosa is a Gram-negative, nosocomial, highly adaptable opportunistic pathogen especially prevalent in immuno-compromised cystic fibrosis (CF) patients. The bacterial cell surface proteins are important contributors to virulence, yet the membrane subproteomes of phenotypically diverse P. aeruginosa strains are poorly characterized. We carried out mass spectrometry (MS)-based proteome analysis of the membrane proteins of three novel P. aeruginosa strains isolated from the sputum of CF patients and compared protein expression to the widely used laboratory strain, PAO1. Microbes were grown in planktonic growth condition using minimal M9 media, and a defined synthetic lung nutrient mimicking medium (SCFM) limited passaging. Two-dimensional LC-MS/MS using iTRAQ labeling enabled quantitative comparisons among 3171 and 2442 proteins from the minimal M9 medium and in the SCFM, respectively. The CF isolates showed marked differences in membrane protein expression in comparison with PAO1 including up-regulation of drug resistance proteins (MexY, MexB, MexC) and down-regulation of chemotaxis and aerotaxis proteins (PA1561, PctA, PctB) and motility and adhesion proteins (FliK, FlgE, FliD, PilJ). Phenotypic analysis using adhesion, motility, and drug susceptibility assays confirmed the proteomics findings. These results provide evidence of host-specific microevolution of P. aeruginosa in the CF lung and shed light on the adaptation strategies used by CF pathogens.

Entities:  

Keywords:  Pseudomonas aeruginosa; bacterial evolution and adaptation; mass spectrometry; membrane proteome; proteomics; virulence

Mesh:

Substances:

Year:  2016        PMID: 27246823     DOI: 10.1021/acs.jproteome.6b00058

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  17 in total

1.  Proteomic profiling of clinical and environmental strains of Pseudomonas aeruginosa.

Authors:  Siew Mun Liew; Savithiri D Puthucheary; Ganeswrei Rajasekaram; Hwa Chia Chai; Kek Heng Chua
Journal:  Mol Biol Rep       Date:  2021-03-16       Impact factor: 2.316

2.  Genome Mining and Predictive Functional Profiling of Acidophilic Rhizobacterium Pseudomonas fluorescens Pt14.

Authors:  Pooja Rani; Nitish Kumar Mahato; Anukriti Sharma; Desiraju Lakshmi Narsimha Rao; Komal Kamra; Rup Lal
Journal:  Indian J Microbiol       Date:  2017-04-18       Impact factor: 2.461

3.  Characterization of the Pseudomonas aeruginosa NQR complex, a bacterial proton pump with roles in autopoisoning resistance.

Authors:  Daniel A Raba; Monica Rosas-Lemus; William M Menzer; Chen Li; Xuan Fang; Pingdong Liang; Karina Tuz; David D L Minh; Oscar Juárez
Journal:  J Biol Chem       Date:  2018-08-22       Impact factor: 5.157

Review 4.  Using bacterial genomes and essential genes for the development of new antibiotics.

Authors:  Francisco R Fields; Shaun W Lee; Michael J McConnell
Journal:  Biochem Pharmacol       Date:  2016-12-08       Impact factor: 5.858

Review 5.  Pseudomonas aeruginosa as a Model To Study Chemosensory Pathway Signaling.

Authors:  Miguel A Matilla; David Martín-Mora; Jose A Gavira; Tino Krell
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-13       Impact factor: 11.056

Review 6.  Recent advances in understanding Pseudomonas aeruginosa as a pathogen.

Authors:  Jens Klockgether; Burkhard Tümmler
Journal:  F1000Res       Date:  2017-07-28

7.  Discovery and Biosynthesis of the Antibiotic Bicyclomycin in Distantly Related Bacterial Classes.

Authors:  Natalia M Vior; Rodney Lacret; Govind Chandra; Siobhán Dorai-Raj; Martin Trick; Andrew W Truman
Journal:  Appl Environ Microbiol       Date:  2018-04-16       Impact factor: 5.005

8.  Identification of FDA-Approved Drugs as Antivirulence Agents Targeting the pqs Quorum-Sensing System of Pseudomonas aeruginosa.

Authors:  Francesca D'Angelo; Valerio Baldelli; Nigel Halliday; Paolo Pantalone; Fabio Polticelli; Ersilia Fiscarelli; Paul Williams; Paolo Visca; Livia Leoni; Giordano Rampioni
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 9.  Technologies for High-Throughput Identification of Antibiotic Mechanism of Action.

Authors:  Bernardo Ribeiro da Cunha; Paulo Zoio; Luís P Fonseca; Cecília R C Calado
Journal:  Antibiotics (Basel)       Date:  2021-05-12

10.  Identification of a Chemoreceptor in Pseudomonas aeruginosa That Specifically Mediates Chemotaxis Toward α-Ketoglutarate.

Authors:  David Martín-Mora; Alvaro Ortega; José A Reyes-Darias; Vanina García; Diana López-Farfán; Miguel A Matilla; Tino Krell
Journal:  Front Microbiol       Date:  2016-11-29       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.